New Treatment Strategies in Aggressive B-Cell Lymphomas: Advances, Application, and a Glimpse of the Future

Download All
Learn how the experts are individualizing treatment selection and managing adverse events associated with established and emerging therapies for patients with MCL and DLBCL in this program centered around a dynamic live symposium at ASCO 2022. Download slides and watch the on-demand webcast from the live symposium, read an expert-authored commentary, and download a clinical summary resource for the discussed agents.
Julie M. Vose, MD, MBA
Program Director
Jeremy S. Abramson, MD, MMSc
Grzegorz Nowakowski, MD

Downloadable Slidesets

Download these slides from a live symposium to gain more insight into the management of MCL.

Julie M. Vose, MD, MBA
Program Director
Released: June 5, 2022

Download these slides from a live symposium to gain more insight into the frontline management of DLBCL.

Grzegorz Nowakowski, MD Released: June 5, 2022

Download these slides from a live symposium to gain more insight into the selection and sequencing of therapies in relapsed/refractory DLBCL.

Jeremy S. Abramson, MD, MMSc Released: June 5, 2022

Clinical Summary Resource

Download this online resource developed to serve as a helpful guide for healthcare professionals on antibody–drug conjugates for aggressive B-cell lymphomas.

Released: June 6, 2022

Download this online resource developed to serve as a helpful guide for healthcare professionals on bispecific antibodies for aggressive B-cell lymphomas.

Released: June 6, 2022

Download this online resource developed to serve as a helpful guide for healthcare professionals on BTK inhibitors for aggressive B-cell lymphomas.

Released: June 6, 2022

Download this online resource developed to serve as a helpful guide for healthcare professionals on CAR T-cell therapies for aggressive B-cell lymphomas.

Released: June 6, 2022

Download this online resource developed to serve as a helpful guide for healthcare professionals on immunomodulatory agents and immune checkpoint inhibitors for aggressive B-cell lymphomas.

Released: June 6, 2022

Download this online resource developed for healthcare professionals with a helpful guide for antibody-based therapies for aggressive B-cell lymphomas.

Released: June 6, 2022

Download this online resource developed to serve as a helpful guide for healthcare professionals on XPO1 and nuclear export inhibitors for aggressive B-cell lymphomas.

Released: June 6, 2022

On-Demand Webcast

In this on-demand webcast from a live symposium, oncology Julie M. Vose, MD, MBA; Jeremy S. Abramson, MD, MMSc; and Grzegorz S. Nowakowski, MD discuss the recent and evolving treatment strategies in the management of patients with aggressive B-cell lymphomas.

Julie M. Vose, MD, MBA
Program Director
Jeremy S. Abramson, MD, MMSc Grzegorz Nowakowski, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: June 8, 2022 Expired: June 7, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Bristol-Myers Squibb
Genmab US, Inc.
Incyte Corporation
Lilly

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings